JCJohn C. Cartee

John C. Cartee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John C. Cartee has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    neissflow: Streamlining Genomic Epidemiology of Neisseria gonorrhoeae with Nextflow

    by Kathryn Morin, Ethan Hetrick, Apurva Shrivastava, Eric Tran, John C. Cartee, Katherine Hebrank, Kim M. Gernert, Matthew W. Schmerer, Sandeep J. Joseph

    Antimicrobial-resistant Neisseria gonorrhoeae ( Ng ) poses a growing global public health threat. Existing tools available for Ng genome analysis carry notable limitations, including incomplete resistance marker coverage, absence of species identification, and lack of phylogenetic capability. We developed neiss-flow, a highly parallelized Nextflow pipeline for Ng genome analysis that integrates five subworkflows: read preprocessing, species identification, de novo assembly, antimicrobial resistance (AMR) profiling, and recombination-aware phylogenetic analysis with outbreak detection. neissflow performs extensive quality control on reads, assemblies, variant calls, and phylogenetic results. Validation was performed on two datasets: a mixed-species dataset (n=158; 105 Ng and 53 non-gonococcal species) for sensitivity/specificity assessment, and a reproducibility dataset (n=283 replicate sequences from 17 reference strains) for consistency and phylogenetic validation. neissflow achieved 100% sensitivity and specificity for Ng species identification compared with MALDI-TOF and PubMLST methods. All nine AMR and typing analytes demonstrated ≥98.1% concordance with PubMLST genotype calls. Genotype-phenotype validation confirmed perfect concordance for key resistance determinants including gyrA mutations with ciprofloxacin resistance, 23S rRNA mutations with high-level azithromycin resistance, and tetM plasmid gene with high-level tetracycline resistance. Reproducibility analysis demonstrated 99.97% concordance across 3,093 analyte calls. Phylogenetic validation demonstrated 100% accuracy for both strain-level and intra-MLST clustering. neissflow is a robust, accessible, and standardized pipeline, positioning it as a valuable tool for public health laboratories engaged in Ng AMR monitoring and outbreak investigations. Importance: Neisseria gonorrhoeae ( Ng ) is the second most common reported bacterial sexually transmitted infection and has developed resistance to all clinically relevant antibiotics. Surveillance of Ng resistance informs clinical recommendations for treatment of gonococcal infections. Whole genome sequencing (WGS) offers powerful insights into resistance mechanisms and transmission dynamics. However, many public health laboratories lack the resources needed to analyze these data effectively. We developed neissflow as an end-to-end, accessible Ng WGS analysis pipeline. neissflow demonstrated exceptional accuracy and reproducibility across diverse reference datasets. neissflow enables broader adoption of whole-genome sequencing-based surveillance and supports timely public health responses to emerging antimicrobial resistance in Ng by lowering technical barriers.

  • Establishing a Neisseria gonorrhoeae whole-genome sequencing external quality assessment for the Antimicrobial Resistance Laboratory Network (AR Lab Network) regional laboratories

    by Jennifer L. Reimche, Amanda C. Smith, Cau D. Pham, Matthew W. Schmerer, John C. Cartee, Carol B. Bolden, Ellen N. Kersh, Kim M. Gernert, Albert Burks, Xiaorong Qian, et al.

    Drug-resistant Neisseria gonorrhoeae (GC) is classified by the Centers for Disease Control and Prevention (CDC) as an urgent threat. Effective surveillance of antimicrobial resistance and strain types through whole-genome sequencing (WGS) is essential to preserve existing antibiotics for treatment. To ensure consistent, high-quality data, we implemented an External Quality Assessment (EQA) program within the Antimicrobial Resistance Laboratory Network in fall 2020. This biannual program distributes five blinded GC reference isolates in triplicate to four regional laboratories for antimicrobial susceptibility testing and WGS. Data were transferred to the CDC for taxonomic classification, assembly, phylogenetics, and quality evaluation. During fall 2020 (pilot)–spring (Cycle 1) 2023, five laboratories (four external; one at CDC) participated in a pilot and five EQA cycles. In the pilot cycle, all laboratories met all quality metrics. However, in 2021 Cycle 1, one laboratory scored below passing (Neisseria gonorrhoeae (GC) is necessary for robust surveillance of antimicrobial resistance (AR)-associated genomic markers and strain prevalence. By ensuring high-quality, consistent WGS data across laboratories participating in genomic surveillance, this program addresses issues identified in sequencing workflows and sample management that were not apparent in routine processing. Eight sequence quality metrics and alignment of phenotypic and genotypic data enhance data reliability, supporting the Centers for Disease Control and Prevention’s efforts to monitor and control drug-resistant GC. The successful implementation of corrective actions after issues discovered in some EQA cycles demonstrates the program’s effectiveness in improving laboratory performance. This program contributes to the fidelity of and capacity for genomic surveillance, identification of AR genomic variants, and public health strategies to reduce GC infections.


  • Open Access

    A novel commensal Neisseria species harboring the gonococcal diagnostic marker DR-9 causes false-positive Roche cobas NAAT results

    by Julio C. Ayala, Shelby M. Hutton, John C. Cartee, Jennifer L. Reimche, Sandeep J. Joseph, Bridgett Herrod, Halie LaPoint, Linda Cao, Tamara Baldwin, Youli Gainey, et al.

    Neisseria gonorrhoeae ( Ng ), the etiologic agent of gonorrhea, is the second most reported bacterial sexually transmitted infection globally. In the USA, nucleic acid amplification tests (NAATs) are considered the gold standard for diagnosis. Although NAATs are sensitive and offer high throughput, cross-reactivity with commensal Neisseria can compromise specificity. Here, we report the isolation and characterization of a novel commensal Neisseria sp. from the oropharynx of a patient with suspected gonococcal treatment failure. An initial diagnosis was made using the Roche cobas CT/NG test on the cobas 8800 system, which repeatedly yielded positive results post-treatment. A confirmatory Aptima Combo 2 (AC2, Hologic) test was negative, and multiple culture attempts failed to isolate Ng . Instead, a commensal Neisseria strain was recovered. Whole-genome sequencing revealed this isolate shared partial genomic identity with several Neisseria spp., including Ng , and carried a distinct region encoding the gonococcal diagnostic marker DR-9, the target of cobas assays. Cross-reactivity was confirmed with the cobas 4800 and 6800 platforms, but not with the AC2 assay targeting 16S rRNA. We discuss the possible origins of the DR-9 marker on this strain as well as examine its antimicrobial susceptibility profile and genomic resistance markers. These findings highlight the potential for misdiagnosis and unnecessary treatment when commensal Neisseria species harbor Ng diagnostic targets. Our study underscores the need for genomic surveillance of Ng and commensal Neisseria , not only to monitor diagnostic performance but also to track commensals that may serve as reservoirs of antimicrobial resistance determinants and contribute to the spread of resistance. IMPORTANCE: Accurate diagnosis of gonorrhea is critical for effective treatment and antimicrobial stewardship. Nucleic acid amplification tests, the mainstay of gonococcal diagnostic testing, can yield false-positive results due to genetic overlap between Neisseria gonorrhoeae and commensal Neisseria species, especially from extragenital sites like the oropharynx. Prior studies, such as Hopkins et al. (2023), have recognized this limitation and proposed supplemental tests to improve specificity for oropharyngeal specimens. Here, we describe a novel commensal Neisseria strain isolated from a patient with suspected treatment failure that harbors the gonococcal diagnostic marker DR-9. This case highlights the need for confirmatory testing using an alternate gene target in cases where repeated positive tests are obtained with extragenital specimens and demonstrates the need for improved test specificity, particularly for anatomical sites such as the pharynx, which has high commensal diversity. Enhanced molecular surveillance of commensal Neisseria populations will be vital for understanding and minimizing diagnostic cross-reactivity.


  • Persistence of Genetically Related Neisseria gonorrhoeae Strains Causing Disseminated Gonococcal Infection Cases in Southwestern Michigan During 2019 to 2023

    by Sandeep J. Joseph, Laura A. S. Quilter, Brian H. Raphael, John C. Cartee, Katherine Hebrank, Kim M. Gernert, Matthew W. Schmerer, Alison D. Ridpath, Neisseria gonorrhoeae Working Group, Elizabeth Burgess, et al.

    Background: Disseminated gonococcal infection (DGI) is a rare complication of Neisseria gonorrhoeae (Ng) infection, historically affecting 0.5% to 3% of individuals. In 2019, a DGI genomic cluster associated with the ST-7822 strain was identified in southwest Michigan. This study retrospectively assessed the persistence of this strain. Methods: Ninety Ng isolates from disseminated sites of infection from Michigan (2019–2023) were sequenced; antimicrobial susceptibility testing was performed. Phylogenetic analysis was performed to assess genetic relatedness. Data from 370 ST-7822 urogenital and extragenital gonococcal infection (UGI) isolates were included in the phylogenetic analysis. The porB1A allele, a marker associated with DGI, and antimicrobial resistance markers were also analyzed. Results: Phylogenetic analysis identified 7 DGI clades, with clade 7 (n = 26) containing the 2019 cluster (n = 11). Clade 7 isolates (mean SNP difference, 32) formed 2 subclusters from a single ancestor between 2019 and 2023 and clustered with local UGI isolates. All clade 7 DGI isolates and 82.7% of ST-7822 UGI isolates carried the porB1A allele. Among DGI isolates with antimicrobial susceptibility testing data (n = 88), all were susceptible to ceftriaxone; no mosaic penA alleles were identified Conclusions: The persistence of clade 7 associated with the 2019 Michigan DGI cluster suggests ongoing regional transmission of the ST-7822 strain type that has a high proportion with porB1A allele, which has been associated with invasive infection. The genetic similarity between DGI and UGI isolates suggests that DGI strains are not genetically distinct but derived from circulating strains causing mucosal infections. Continued genomic surveillance is essential to understand virulence factors contributing to disseminated infections.


  • Open Access

    Phylogenomic Comparison of Neisseria gonorrhoeae Causing Disseminated Gonococcal Infections and Uncomplicated Gonorrhea in Georgia, United States

    by John C Cartee, Sandeep J Joseph, Emily Weston, Cau D Pham, Jesse C Thomas, Karen Schlanger, Sancta B St Cyr, Monica M Farley, Ashley E Moore, Amy K Tunali, et al.

    Disseminated gonococcal infection (DGI) is a rare complication caused by the systemic dissemination of Neisseria gonorrhoeae to normally sterile anatomical sites. Little is known about the genetic diversity of DGI gonococcal strains and how they relate to other gonococcal strains causing uncomplicated mucosal infections. We used whole genome sequencing to characterize DGI isolates (n = 30) collected from a surveillance system in Georgia, United States, during 2017–2020 to understand phylogenetic clustering among DGI as well as uncomplicated uro- and extragenital gonococcal infection (UGI) isolates (n = 110) collected in Fulton County, Georgia, during 2017–2019. We also investigated the presence or absence of genetic markers related to antimicrobial resistance (AMR) as well as surveyed the genomes for putative virulence genetic factors associated with normal human-serum (NHS) resistance that might facilitate DGI. We found that DGI strains demonstrated significant genetic variability similar to the population structure of isolates causing UGI, with sporadic incidences of geographically clustered DGI strains. DGI isolates contained various AMR markers and genetic mechanisms associated with NHS resistance. DGI isolates had a higher frequency of the porB1A allele compared with UGI (67% vs 9%, P < .0001); however, no single NHS resistance marker was found in all DGI isolates. Continued DGI surveillance with genome-based characterization of DGI isolates is necessary to better understand specific factors that promote systemic dissemination.


  • Open Access

    Whole-Genome Enrichment and Sequencing of Chlamydia trachomatis Directly from Patient Clinical Vaginal and Rectal Swabs

    by Katherine E. Bowden, Sandeep J. Joseph, John Cartee, Noa Ziklo, Damien Danavall, Brian H. Raphael, Timothy D. Read, Deborah Dean

    Chlamydia trachomatis is the most prevalent cause of bacterial sexually transmitted infections (STIs) worldwide. U.S. cases have been steadily increasing for more than a decade in both the urogenital tract and rectum. C. trachomatis is an obligate intracellular bacterium that is not easily cultured, limiting the capacity for genome studies to understand strain diversity and emergence among various patient populations globally. While Agilent SureSelect XT target-enrichment RNA bait libraries have been developed for whole-genome enrichment and sequencing of C. trachomatis directly from clinical urine, vaginal, conjunctival and rectal samples, efficiencies are only 60-80% for ≥95-100% genome coverage. We therefore re-designed and expanded the RNA bait library to augment enrichment of the organism from clinical samples to improve efficiency. We describe the expanded library, the limit of detection for C. trachomatis genome copy input, and the 100% efficiency and high-resolution of generated genomes where genomic recombination among paired vaginal and rectal specimens from four patients was identified. This workflow provides a robust approach for discerning genomic diversity and advancing our understanding of the molecular epidemiology of contemporary C. trachomatis STIs across sample types, among geographic populations, sexual networks, and outbreaks associated with proctitis/proctocolitis among women and men who have sex with men. Importance: Chlamydia trachomatis is an obligate intracellular bacterium that is not easily cultured, and there is limited information on rectal C. trachomatis transmission and its impact on morbidity. To improve efficiency of previous studies involving whole genome target enrichment and sequencing of C. trachomatis directly from clinical urine, vaginal, conjunctival, and rectal specimens, we expanded the RNA bait library to augment enrichment of the organism from clinical samples. We demonstrate an increased efficiency in the percentage of reads mapping to C. trachomatis . We show the new system is sensitive for near identical genomes of C. trachomatis from two body sites in four women. Further, we provide a robust genomic epidemiologic approach to advance our understanding of C. trachomatis strains causing ocular, urogenital and rectal infections, and to explore geo-sexual networks, outbreaks of colorectal infections among women and men who have sex with men, and the role of these strains in morbidity.